-
Real-World Utilization Pattern of GLP-1 Receptor Agonists in German Outpatient Care
Sep 9, 2025, 16:22 PM -
Measurement Properties of the EQ-5D in Hematological Cancers: A Systematic Review
Sep 9, 2025, 16:22 PM -
A Budget Impact Model of Switching From Self-Monitoring of Blood Glucose to Continuous Glucose Monitoring for Individuals With Type 2 Diabetes Mellitus Receiving Basal Insulin in Italy
Sep 9, 2025, 16:22 PM -
Socioeconomic Disparities in Access to Treatment for Major Depressive Disorder: The Role of Accumulator and Maximizer Insurance Plans
Sep 9, 2025, 16:22 PM -
Unlocking the Value of RSV Adult Vaccination With Adjuvanted RSVpreF3 Vaccine in Germany: A Return on Investment Analysis Using an Integrated Actuarial-Macroeconomic Model
Sep 9, 2025, 16:22 PM -
Advancing a Greener Ecosystem in Health Technology Assessment: A Review of Environmental Integration as an Additional Value Driver
Sep 9, 2025, 16:22 PM -
The Impact of the Introduction of Diagnosis-Related Groups (DRG)-Based Hospital Financing on the Performance of Romanian Hospitals
Sep 9, 2025, 16:22 PM -
The Landscape of the Use of Artificial Intelligence and Machine Learning (AIMI) Methods in Health Technology Assessment (HTA) Submissions
Sep 9, 2025, 16:22 PM -
Stakeholder Mapping and Policy Assessment of Rare Diseases in Southeast Asia
Sep 9, 2025, 16:22 PM -
Adoption and Evidence Generation in NICE Early Value Assessments (EVA) for Medtech: Trends Across 2023-2025
Sep 9, 2025, 16:22 PM -
How Far Have We Come With EQ-5D-5L Value Sets? An Updated Systematic Literature Review of 55 Valuation Studies
Sep 9, 2025, 16:22 PM -
Health Halo Effect in Supplement Marketing: A Content Analysis of Medical Claims in Community Pharmacies
Sep 9, 2025, 16:22 PM -
From Cost Containment to Modernization: Market Access Updates Across the EU4 and the UK in 2025
Sep 9, 2025, 16:22 PM -
Workforce and Environmental Impact of Home-Based vs. Hospital-Based Administration of Second-Line MS Therapies in the Netherlands: A Comparative Analysis of Personnel Time and Carbon Footprint
Sep 9, 2025, 16:22 PM -
Studying Paternal Drug Exposures and Offspring Outcomes: A Feasibility Assessment of 11 Large European Databases
Sep 9, 2025, 16:22 PM -
Data Linkage to Support Real-World Evdence in Rare Disease
Sep 9, 2025, 16:22 PM -
Can Generative AI Automate Health Economic Model Verification?
Sep 9, 2025, 16:22 PM -
Public Health and Economic Impact of RSVpreF Maternal Vaccination Among Infants in Five Asian Countries
Sep 9, 2025, 16:22 PM -
Economic Evaluation of Synovial Biopsy-Guided Treatment Strategy After TNF-Alpha Inhibitor Failure in Rheumatoid Arthritis
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Lebrikizumab vs. Alternative Biologics in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis in the UK
Sep 9, 2025, 16:22 PM
